# Biological Response to Platelet-rich Plasma and Corticosteroid Injections

> **NCT05657496** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Missouri-Columbia** · enrollment: 23 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** Triamcinolone Acetonide 40 mg/ml Inj, Susp
- **BIOLOGICAL:** Platelet-rich plasma Inj

## Key facts

- **NCT ID:** NCT05657496
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-12-28
- **Primary completion:** 2025-06-18
- **Final completion:** 2025-06-18
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Principal Investigator is Retiring.
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05657496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05657496, "Biological Response to Platelet-rich Plasma and Corticosteroid Injections". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05657496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*